Results

Total Results: over 10,000 records

Showing results for "description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_disposition-comments.pdf
    July 17, 2013 - This has been corrected in the “Description of Included Studies” for this comparison, in Table 10 (Drugs … and Usability It might be beneficial if the Authors reviewed the document for consistency of the description … In the Results section, funding is reported in the narrative description of the evidence for each comparison … Description of PICOTS was nicely done and a new term for me, one who spends the day seeing patients.
  2. Imp-Handouts (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/imp-handouts.pdf
    June 02, 2025 - We include a description of the problem, current diagnoses, any recent lab or x ray results, and the … Reports Can Be Used (for use with Implementation Scripted Exercise) Nursing Home Meetings Meeting Description … Program for Nursing Homes: On-Time Preventable Hospital and ED Visits 2 Nursing Home Meetings Meeting Description … Program for Nursing Homes: On-Time Preventable Hospital and ED Visits 3 Nursing Home Meetings Meeting Description
  3. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-fullreport.pdf
    March 01, 2019 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample
  4. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
    December 01, 2019 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample
  5. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fullreport.pdf
    March 01, 2018 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
    March 19, 2018 - Further description as to the domains that led to downgrading a given outcome are provided in the … Further description as to the domains that led to downgrading a given outcome within each intervention … Further description as to the domains that led to downgrading a given outcome within each intervention … Public reviewer #1, Anonymous KQ1c A description of how dosing (frequency and cumulative dose) differs
  7. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
    February 01, 2018 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
    April 01, 2024 - Bias Study Design (n Analyzed) Patient Population Setting/Care Transition Condition Description … Bias Study Design (n Analyzed) Patient Population Setting/Care Transition Condition Description … Bias Study Design (n Analyzed) Patient Population Setting/Care Transition Condition Description … Bias Study Design (n Analyzed) Patient Population Setting/Care Transition Condition Description … Bias Study Design (n Analyzed) Patient Population Setting/Care Transition Condition Description
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_disposition-comments.pdf
    July 14, 2016 - discussion of the study by Putkonen and colleagues (2013), the text describes on p. 66 gives an excellent description
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - Definition and description of schizophrenia in the DSM-5.
  11. www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/item-sets/elicitation/about-patient-narratives-elicitation-protocol-cg30-2315.pdf
    April 24, 2018 - CropGrayImages false /CropMonoImages false /DSCReportingLevel 0 /DefaultRenderingIntent /Default /Description
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
    May 01, 2013 - Orienting Stakeholders The stakeholders were provided by email a description of the project, the draft … this report. 6 Orienting Stakeholders By emailed letters we provided the stakeholders with a description … and assessed one to three study design suggestions for each of the final FRN, with limited textual description … List of Ongoing Studies Title/ Identifier(s) Study Dates Description Sponsor or Principal Investigator … Accessed at: clinicaltrials.gov/ct2/show/NC T01469819 B-2 Title/ Identifier(s) Study Dates Description
  13. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
    May 01, 2005 - Description of risk-of-bias categories and study design-specific assessment criteria for randomized … The Cochrane Handbook of Systematic Reviews offers a more detailed description of intention to treat … Description of risk-of-bias categories and study design-specific assessment criteria for randomized and … Categories of Bias Related to Design and Conduct of the Studyb Description … A misleading subgroup analysis may not fit the classic description of bias or confounding, but can
  14. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary20/suicide-risk-in-adolescents-adults-and-older-adults-screening
    April 15, 2013 - * Weights are from random-effects analysis Text Description . … * Weights are from random-effects analysis Text Description . … * Weights are from random-effects analysis Text Description . … Text Description . … Text Description .
  15. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
    April 13, 2015 - Text Description. … Text Description. … * Included in the 2008 report. 22 Text Description. … * Included in the 2008 report. 22 Text Description. … * Included in the 2008 report. 22 Text Description.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01_0.pdf
    May 01, 2005 - Description of risk-of-bias categories and study design-specific assessment criteria for randomized … The Cochrane Handbook of Systematic Reviews offers a more detailed description of intention to treat … Description of risk-of-bias categories and study design-specific assessment criteria for randomized and … Categories of Bias Related to Design and Conduct of the Studyb Description … A misleading subgroup analysis may not fit the classic description of bias or confounding, but can
  17. www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-4-practice-management.pdf
    September 01, 2015 - Clinical staff and descriptions Discipline/ Degree Description Medical doctor (M.D.) and doctor … Primary Care Practice Facilitation Curriculum MODULE 4 M4-11 Discipline/ Degree Description Registered … Table 4.3 provides a list and description of commonly used coding systems. Table 4.3.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nppv-respiratory-failure_research-protocol.pdf
    April 21, 2011 - Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_research-protocol.pdf
    January 13, 2014 - Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  20. www.ahrq.gov/pqmp/implementation-qi/toolkit/asthma/qi-strategies.html
    July 01, 2021 - For a more detailed description of the approach that was adapted, refer to the article entitled “ A